Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis

This study has been terminated.
(Low enrollment)
Sponsor:
Collaborators:
MADAUS GmbH
The Egyptian Company for Blood Transfusion Services (EgyBlood)
Tanta Fever Hospital
Banha Fever Hospital
Alexandria University
Information provided by (Responsible Party):
Samer S. El-Kamary, University of Maryland
ClinicalTrials.gov Identifier:
NCT00755950
First received: September 17, 2008
Last updated: October 25, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2012
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)